Study finds that drink supplementation for 12 weeks improves delayed verbal recall
MONDAY, Jan. 11 (HealthDay News) -- Patients with very mild Alzheimer's disease show improvements in memory after taking a multi-nutrient drink designed to improve synapse formation, according to a study in the January issue of Alzheimer's & Dementia.
Philip Scheltens, M.D., of VU University Medical Center in Amsterdam, Netherlands, and colleagues randomly assigned 225 patients with mild Alzheimer's disease to Souvenaid, a multi-nutrient drink, or a control drink once a day for 12 weeks.
The researchers found that Souvenaid was well tolerated and that patients taking Souvenaid had significant improvement in the delayed verbal recall task. However, no changes were observed in several other scores examining outcomes such as quality of life. Patients taking the control drink showed no changes.
"Supplementation with a medical food including phosphatide precursors and cofactors for 12 weeks improved memory (delayed verbal recall) in mild Alzheimer's disease patients," the authors conclude.
One author is an employee of Danone Research, and several others reported advisory or consulting relationships with Danone and Nutricia. Another author works at an academic medical center that receives unrestricted funding from Danone Research.
Abstract
Full Text (subscription or payment may be required)